DNA damage persistence as determinant of tumor sensitivity to the combination of Topo I inhibitors and telomere-targeting agents.

Source:http://linkedlifedata.com/resource/pubmed/id/21355072

Clin. Cancer Res. 2011 Apr 15 17 8 2227-36

Download in:

View as

General Info

PMID
21355072